Effect of Trypan Blue on Corneal Endothelial Cell Count During Phacoemulsification
Key facts
- Who runs it
- Hayat Abad Medical Complex, Peshawar
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 22 Mar 2024
- Ended
- 22 Sept 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Trypan Blue
- Phacoemulcification
- Record updated
- 30 July 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Adults aged 45 to 75 years
- Diagnosed with age-related cataract
- Scheduled to undergo phacoemulsification with posterior chamber intraocular lens implantation
- Able and willing to provide written informed consent
Who cannot take part
- Previous ocular surgery
- Diabetes mellitus
- Pre-existing corneal endothelial disease
- Any other ocular pathology that could affect corneal endothelial cell count or interfere with study outcomes
- Glaucoma
- Corneal opacity
- Uveitis
- Traumatic cataract
- Complicated cataract
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial evaluated the effect of trypan blue on corneal endothelial cell count in patients undergoing phacoemulsification for age-related cataract. Sixty participants were randomly assigned to undergo phacoemulsification either with trypan blue-assisted anterior capsule staining or without trypan blue. The primary objective was to compare postoperative corneal endothelial cell count between the two groups using specular microscopy to determine whether trypan blue has an effect on corneal endothelial cell loss during cataract surgery.
The 2 groups in the trial
- Trypan Blue GroupTreatment being tested
Participants underwent standard phacoemulsification with intracameral trypan blue staining of the anterior lens capsule before capsulorhexis, followed by intraocular lens implantation using a standardized surgical technique
Treatment: Trypan Blue and Phacoemulcification
- Control GroupExisting treatment, for comparison
Participants underwent standard phacoemulsification without trypan blue staining of the anterior lens capsule, followed by intraocular lens implantation using the same standardized surgical technique.
Treatment: Phacoemulcification
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 30 July 2026